TrialDrugs & aging2015

Phase II Study of a Platinum-Based Adapted Chemotherapy Regimen Combined with Radiotherapy in Patients 75 Years and Older with Esophageal Cancer.

Stéphanie Servagi-Vernat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.